ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA

E. Canaani*, D. Steiner-Saltz, E. Aghai, R. P. Gale, A. Berrebi, E. Januszewicz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Abstract

The oncogene abl, which resides on chromosome 9, is translocated to chromosome 22 as part of the Philadelphia (Ph1) chromosome. Leukaemic cells from 5 of 6 patients with chronic myelogenous leukaemia (CML) and the Ph1 chromosome were found to contain a new 8 kb abl RNA transcript. This finding raises the possibility that the abl oncogene is directly involved in the development of CML. It is suggested that the abl gene's expression is altered by the DNA rearrangement in the translocation.

Original languageAmerican English
Pages (from-to)593-595
Number of pages3
JournalThe Lancet
Volume323
Issue number8377
DOIs
StatePublished - 17 Mar 1984
Externally publishedYes

Fingerprint

Dive into the research topics of 'ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA'. Together they form a unique fingerprint.

Cite this